Archives: Press

Milo Biotechnology Announces FDA Orphan Drug Designation for Treatment of Inclusion Body Myositis
Today’s Form D Alert Complion $2.90 million Fundraising. Richard Arlow Released Oct 4 D Form
Research Reveals Major Impacts Of Angels — And Some Angel Groups Outperform VCs
15 Things Entrepreneurs Need to Know: Rev1 Fund1
Innovative Funding at the Edges: Rev1 Fund I
nChannel Named a Multichannel Merchant Top Commerce Platform for 2017
Five Takeaways From Nexosis First Target + Techstars’ Demo Day
Updox Named Greenway Health Partner of the Year
CropZilla’s Software Helping Farmers Maximize Profits